Andrew Mazar Email

Co-Founder and EVP, Research and Development Chief Scientific Officer . Monopar Therapeutics Inc. (MNPR)

Wilmette, IL

Location

m****@monopartx.com

Primary Email

LinkedIn

Current Roles

Employees:
20
Revenue:
$3.1M
About
Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19.
Monopar Therapeutics Inc. (MNPR) Address
1000 Skokie Blvd.
Wilmette, IL
United States
Monopar Therapeutics Inc. (MNPR) Email
Monopar Therapeutics Inc. (MNPR) Phone Numbers
847-388-0349

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.